Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci.
Sparfloxacin, a new fluorinated quinolone, exhibits higher in vitro activity against pneumococci than do ciprofloxacin and ofloxacin. Since up to 30% of cases of pneumococcal pneumonia are associated with bacteremia, and since an increasing percentage of pneumococci are resistant against penicillin,...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1996
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163197/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8851610/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.3.776 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|